Match Document Document Title
US20120148670 SENSITIVE POLYMER CAPSULE AND METHOD OF MANUFACTURING THE SAME  
A polymer capsule manufactured by polymerizing a compound represented by Formula 1, or polymerizing the compound of Formula 1 and a compound of Formula 2, wherein a detailed structure of the...
US20100330167 Nanoparticles for protein drug delivery  
The invention discloses the nanoparticles composed of chitosan, poly-γ-glutamic acid, and at least one bioactive agent characterized with a positive surface charge and their enhanced permeability...
US20070254023 Perorally Administrable Antimicrobial Composition  
The invention relates to medicine and the chemical and pharmaceutical industry, in particular to antibiotic preparative forms. The inventive antimicrobial composition contains antibiotic selected...
US20110182807 Method and Dosage Form to Confirm Compliant Use of a Bioactive Agent  
A dosage form includes a dose of at least one bioactive agent and a substance that can be readily confirmed by medical personnel to determine if the patient is compliant with taking the dosage...
US20070060648 Lipids from methanotrophic bacteria for cholesterol reduction  
The present invention provides the use of lipids from methanotrophic bacteria for the manufacture of a composition for oral administration for use in the treatment of animal subjects to reduce...
US20070082044 Synergistic effect of compositions comprising carotenoids selected from lutein, beta-carotene and lycopene  
The methods of the invention can be used to protect against lymphocyte DNA damage and free-radical associated disorders in a subject. The methods of the present invention can be used to increase...
US20110091540 POLYMERIC COMPOSITIONS AND THEIR METHOD OF USE IN COMBINATION WITH ACTIVE AGENTS  
A combination of active agents is disclosed which are particularly useful for treating fluid overload conditions. Methods for using the combination of active agent are also disclosed. The...
US20060165774 Non gelatin films with improved barrier properties  
Non gelatin film materials, e.g. hydroxy propyl methyl cellulose comprise e.g. an additive or additives such as an organic acid, e.g. hydroxy carboxylic acid, which form a barrier composition. The...
US20080107726 COMPOSITIONS COMPRISING BETA-ADRENERGIC RECEPTOR ANTAGONISTS AND DIURETICS  
Pharmaceutical compositions comprise beta-adrenergic receptor blocking agents for controlled release and diuretics for immediate release. In an embodiment, a composition comprising metoprolol...
US20060110332 Agent for medicamentous treatment of acute and chronic pain  
The invention relates to an agent for the medicamentous treatment of acute and chronic pain, in particular of allodynia and hyperalgesia. Fields of application of the invention are medice and the...
US20070224259 ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION  
The present invention provides an orally administrable capsule comprising at least two mini-tablets, or at least two mini-capsules, or a combination of at least a mini-tablet and a mini-capsule,...
US20140328907 ENTRAPMENT OF BIOACTIVES IN SOL-GEL ALUMINA MATERIALS  
Provided is a platform for entrapment within alumina sol-gel carriers of labile biologically active materials such as proteins, therapeutic enzymes, enzymes of industrial relevance, antigens, and...
US20050163824 Modified polymeric films  
A hydroxypropyl methyl cellulose film comprises hydroxypropyl methyl cellulose plasticised with a plasticiser comprising an organic acid or a salt of an organic acid, preferably lactic acid, or an...
US20130295170 COMPOSITIONS FOR CONTROL OF DRUG ABUSE  
Opiates, amphetamines, barbiturates and other drugs such as benzodiazepines are extensively abused or misused and are frequently the cause of death by overdosing. These drugs are also prone to...
US20150140088 SPIROSTEROID SYSTEMS ACTING AS NEUROPROTECTIVE AND ANTI-INFLAMMATORY AGENTS  
The present invention relates to the fields of chemistry and pharmacy and, in particular, to the production of novel molecular entities: esterane derivatives fused with spirostanes rings, acting...
US20130129822 LIQUID-FILLED HARD GEL CAPSULE PHARMACEUTICAL FORMULATIONS  
Embodiments of liquid-filled hard gel capsule pharmaceutical formulations comprise a non-emulsified mixture, wherein the non-emulsified mixture comprises about 0.1 to about 5% by weight of at...
US20090022786 Oral pharmaceutical dosage form and manufacturing method thereof  
The present invention provides an coated oral pharmaceutical dosage form comprising a composition of a non-steroidal anti-inflammatory drug (NSAID) as multilayered spherical granule combined with...
US20110189272 PHARMACEUTICAL PREPARATION CONTAINING GABAPENTIN  
A method for preparing a gabapentin granulate comprising melt granulating gabapentin with polyethylene glycol having a melting point comprised between 50 and 80° C.
US20060257385 Dietary supplement formulations for improved delivery of coenzyme Q10 and methods of administration  
A dietary supplement comprising Coenzyme Q10 (i.e. ubiquinone) and a bioadhesive substance is described. Derivatives of Coenzyme Q10 may also be used in the dietary supplement. The dietary...
US20130295172 Medical compositions, methods of making and using those compositions, and kits including those compositions  
Disclosed here are compositions comprising powdered hemp seed, an emulsifier/dispersant such as lecithin (particularly soya lecithin), cannabis, and optionally other additives and excipients. Also...
US20100255085 Progesterone Solutions for Increased Bioavailability  
Fill materials for hydrophobic drugs, such as progesterone, and methods of making and using thereof are described herein. The fill material contains the hydrophobic drug dissolved in one or more...
US20060051298 Abuse resistent pharmaceutical dosage and method of making same  
A pharmaceutical composition includes a therapeutic amount of an active ingredient and at least one gel-forming granule. The gel-forming granule forms a gel when exposed to an aqueous liquid and...
US20050170014 Carbonyl iron pharmaceutical dosage forms for the treatment of iron-deficiency anemia  
The present invention relates to a pharmaceutical composition including an active pharmaceutical ingredient for the treatment of iron-deficiency anemia and related disorders. The active...
US20060177497 Gellan gum based oral controlled release dosage forms-a novel platform technology for gastric retention  
A controlled-release dosage form is described, which comprises a matrix formed of ingredients (a) and (b): (a) gellan gum, and (b) one or more hydrophilic polymers; and further comprising a drug...
US20120003303 ORAL ENTERIC ANTIDEPRESSANT FORMULATION  
Pharmaceutical presentations of phenoxathiin-based MAO-A inhibitors are disclosed whereby the MAO receptors are protected from binding to active ingredient in the stomach. Particular...
US20130259930 Compositions and Methods for Preventing and Treating Mucositis and Weight Loss  
Pharmaceutical compositions comprising 5-[2-pyrazinyl]-4-methyl-1,2-3-thione or an analogue, derivative, metabolite, prodrug, solvate or a pharmaceutically acceptable salt thereof; and a...
US20140220118 SOLID FORMULATIONS OF OSPEMIFENE  
This invention relates to a solid drug formulation comprising granulates containing• a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically...
US20050287204 Nutritional or pharmaceutical compositions for increasing the creatine response of organisms  
There is provided a nutritional or pharmaceutical composition comprising a protein fraction containing L-serine and an energy metabolism precursor wherein the composition is free of glycine or if...
US20070116743 Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose  
A health food/dietary supplement is disclosed suitable for enhancing muscular energy metabolism, comprising as its characterizing active ingredits an alkanoyl L-carnitine and ribose.
US20070053930 Combination therapy for treatment of high cholesterol  
Compositions and convenient methods for the delivery of a therapeutic combination of statins such as mevinolin, with niacin and ginkgo to patients with high blood cholesterol are provided.
US20090110721 Paneled capsule shells for release of pharmaceutical compositions  
Capsule shells for use in multi-part dosage forms have generally cylindrical shell members with a snap fit component on an interior surface adjacent an open end, for connection to a linker part of...
US20150110865 CNS STIMULANT AND OPIOID RECEPTOR ANTAGONIST COMBINATION AS A NON-ADDICTIVE, NON-AVERSIVE AND SYNERGISTIC ANTI-OBESITY TREATMENT  
Combinations comprise a therapeutically effective amount of one or more stimulants and and/or pharmaceutically acceptable analogs, salts, or hydrates of the one or more stimulants, and one or more...
US20130071472 Fascile synthesis of biocompatible polymer capsule nanoparticles for drug encapsulation  
The present invention relates to a method for preparing a capsule nanoparticle used in encapsulating hydrophobic medicines, comprising the following steps: (A) providing a biocompatible polymer...
US20070154541 Seamless capsule containing water-soluble active substance  
A seamless capsule containing a water-soluble active substance in which the water-soluble active substance is protected from becoming unstable and a process for producing the same. The seamless...
US20140302127 Novel formulation of metaxalone  
The present invention relates to methods for producing particles of metaxalone using dry milling processes as well as compositions comprising metaxalone, medicaments produced using metaxalone in...
US20110033526 PHARMACEUTICAL COMPOSITION OF ANTIBIOTICS AND PREBIOTICS FOR PREVENTING AND TREATING DYSBIOSIS DURING ANTIBACTERIAL THERAPY  
The invention relates to medicine and pharmacology, in particular to pharmaceutical compositions containing the following antimicrobial preparations: antibiotics and sulphanylamides combined with...
US20090081285 USE OF RADICAL-CAPTURING SUBSTANCES IN A TOPICAL PREPARATION FOR ANTIPYRETIC TREATMENT  
The present invention relates to the use of one or more radical-capturing substances as therapeutically active substances in a topical preparation for antipyretic treatment. The invention is also...
US20050244490 Dosing methods for beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine antiviral therapy  
The disclosed invention is a composition for and a method of treating a HIV infection in a host, such as a human, using a single, once a day, oral dose of β-D-D4FC in an enteric-coated tablet. The...
US20120288561 DELAYED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF  
Methods and compositions for reducing the frequency of urination are disclosed. One method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition...
US20090162428 Immediate disintegration polyvalent polymeric matrix for modified release solid oral preparations and method of preparation thereof  
An immediate disintegrating polymeric matrix for oral administration with modified release is disclosed, obtained without using inert supports such as sugar spheres, comprising particles of active...
US20090148514 Multipart capsule for staged release of one or more pharmaceutical compositions  
A multipart capsule, e.g., a dosage form, is provided which includes a plurality of capsule portions, at least one of which contains a substance to be released into a gastro-intestinal environment...
US20130022671 CONTROLLED RELEASE COMPOSITIONS OF AGENTS THAT REDUCE CIRCULATING LEVELS OF PLATELETS AND METHODS THEREFOR  
Provided are prophylactic and therapeutic methods of treatment of subjects for the purpose of inhibiting vaso-occlusive events, including embolism, by administering agents, including anagrelide...
US20070128270 PHARMACEUTICAL FORMULATIONS CONTAINING 5-CYCLOPROPYL-2-(4-FLUOROPHENYL)-6-[(2-HYDROXYETHYL)(METHYLSULFONYL)AMINO]-N-METHYL-1-BENZOFURAN-3-CARBOXAMIDE AND METHOD OF MAKING THE SAME  
Pharmaceutical formulations containing 5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methyls ulfonyl)amino]-N-methyl-1-benzofuran-3-carboxamide and pharmaceutically acceptable additives...
US20100129435 Methods and compositions for treatment of ocular neovascularization and neural injury  
Methods and compositions for the treatment of ocular neovascularization and macular degeneration. The invention includes combining photodynamic therapy with administration of a neuroprotectant and...
US20100136102 TERPENE-CONTAINING COMPOSITIONS AND METHODS OF MAKING AND USING THEM  
The present invention relates to compositions comprising terpenes and hollow glucan particles or cell wall particles and methods for preparing such compositions. The compositions increase terpene...
US20090191217 Anti-IL-1R1 Single Domain Antibodies And Therapeutic Uses  
Disclosed is the use of an antagonist of Interleukin 1 receptor type 1 (IL-1R1) for the manufacture of a medicament treating, preventing or suppressing lung inflammation or a respiratory disease....
US20100129439 Adjuvant Incorporation in Immunonanotherapeutics  
The present invention provides compositions and systems for delivery of nanocarriers to cells of the immune system. The invention provides nanocarriers capable of stimulating an immune response in...
US20100172969 HOT-MELT MICROPELLETS  
The present invention provides a method of making solid micropellets of which at least 75% by weight have a diameter less than 500 μm comprising (i) melting one or more binders; and (ii) combining...
US20050142185 Softgel formulations of bisphosphonates bone resorption inhibitors  
The present invention provides a pharmaceutical formulation suitable for filling softgel capsules comprising: (a) from about 1% to about 90% by weight of a bisphosphonic acid or a pharmaceutically...
US20110135720 Polymer coatings containing phytochemical agents and methods for making and using same  
This invention relates to compositions comprising a polymer base incorporating antifouling compositions suitable for use in aquaculture, marine and architectural systems as paints, structures or...